NCT02807207View on ClinicalTrials.gov

To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Subjects
Interventions
DRUG

A: pacritinib

Treatment A

OTHER

B: Placebo

Treatment B

DRUG

C: moxifloxacin

Treatment C

Trial Locations (1)

47710

Covance Clinical Research Unit Inc., Evansville

Sponsors

Lead Sponsor

CTI BioPharma

Collaborators (1)

Covance
All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

CTI BioPharma

INDUSTRY

NCT02807207 - To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects | Biotech Hunter | Biotech Hunter